Skip to main content

Table 5 Grade 3 or 4 adverse events with an incidence of > 3%

From: Abiraterone acetate for chemotherapy-naive metastatic castration-resistant prostate cancer: a single-centre prospective study of efficacy, safety, and prognostic factors

Grade 3/4 AEs(reported in ≥3% of patients)

AA group

Prednisone-alone group

ALT increased

11.6% (5 of 43)

11.8% [2 of 17]

Hypokalaemia

9.3% (4 of 43)

11.8% [2 of 17]

Hyperglycaemia

4.7% (2 of 43)

5.9% [1 of 17]

  1. Abbreviations: ALT Alanine aminotransferase, AA abiraterone acetate